NEW DELHI: Fifty lakh doses of ‘Covishield vaccine earmarked by the Serum Institute for export to the United Kingdom have now been made available for the inoculation of 18-44 age group in 21 states/UTs in India, amid a surge in Covid-19 cases, official sources said.
The Centre s decision to allocate these doses to 21 states and Union territories (UTs) came after Prakash Kumar Singh, director, Government and Regulatory Affairs at Pune-based Serum Institute of India, recently wrote to the Union health ministry seeking permission for the same.
The Serum Institute had on March 23 sought permission from the ministry to supply 50 lakh doses of Covishield to the UK, citing an agreement with AstraZeneca in this regard, while assuring India that its own anti-coronavirus vaccination programme will not be disturbed due to this supply.
50 lakh Covishield doses meant for export to UK to be used in India for vaccinating 18-plus
SECTIONS
50 lakh Covishield doses meant for export to UK to be used in India for vaccinating 18-plusPTI
Last Updated: May 07, 2021, 08:27 PM IST
Share
Synopsis
The Centre s decision to allocate these doses to 21 states and Union territories (UTs) came after Prakash Kumar Singh, director, Government and Regulatory Affairs at Pune-based Serum Institute of India, recently wrote to the Union health ministry seeking permission for the same.
AFP
The Serum Institute had on March 23 sought permission from the ministry to supply 50 lakh doses of Covishield to the UK.
IP waiver: US move may help ramp up vax capacity
Top Searches
IP waiver: US move may help ramp up vax capacity
Rupali Mukherjee / TNN / Updated: May 7, 2021, 06:28 IST
FacebookTwitterLinkedinEMail
Mumbai: The US policy U-turn of supporting waiver of intellectual property on Covid vaccines could help developing countries like India to manufacture patented vaccines, as well as those which are not yet available in the country. These may include vaccines from UK’s AstraZeneca, US firms J&J, Pfizer, Moderna and Novavax, Russia’s Gamaleya Center, and domestic firm Bharat Biotech.
The US said it would also participate in World Trade Organization (WTO) negotiations to support the temporary waiving of protections, and work with the private sector and other partners to expand vaccine manufacturing and distribution.
Highlights
A Petition has been filed in Bombay HC seeks Z+ security for Serum Institute of India CEO, his family
Petition informed the cough that Adar Poonawalla has been receiving threats from powerful persons
Mumbai: A writ petition has been filed in the Bombay High Court seeking Z plus security for Serum Institute of India CEO Adar Poonawalla and his family.
The petitioner, filed by advocate Datta Shrirang Mane, said that
Adar Poonawalla and his family should be given Z plus security, and his assets should be protected keeping the threats that were being made to Poonawallah as per media reports.
PREMIUM
BENGALURU, INDIA - APRIL 30: A man wearing PPE (Personal Protective Equipment) performs the last rites of a deceased relative in a disused granite quarry repurposed to cremate the dead due to COVID-19 on April 30, 2021 in Bengaluru, India. (Photo by AND so, it begins, the pulling up of the ladder. Come to think of it, the warning signs have been there for some considerable time now. After all, there’s nothing like a threat to one and all for some to see it simply as a threat to themselves alone and the rest be damned. I’m talking about the Covid-19 pandemic and the insightful and sometimes rather unedifying responses to it by those countries that have adequate defences, towards those countries that do not.